Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/30/25
United Therapeutics Corporation Reports Record Second Quarter 2025 Financial ResultsBusiness Wire • 07/30/25
United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for InvestorsZacks Investment Research • 07/24/25
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 07/23/25
United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025Business Wire • 07/16/25
United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered LiverBusiness Wire • 06/24/25
United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial HypertensionBusiness Wire • 06/23/25
United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?Zacks Investment Research • 06/13/25
Why Is United Therapeutics (UTHR) Up 9% Since Last Earnings Report?Zacks Investment Research • 05/30/25
UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso SalesZacks Investment Research • 05/01/25
United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/30/25
United Therapeutics (UTHR) Q1 Earnings and Revenues Top EstimatesZacks Investment Research • 04/30/25
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International ConferenceBusiness Wire • 04/21/25
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific SessionsBusiness Wire • 04/04/25
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025Business Wire • 03/04/25